Faricimab for treating diabetic macular oedema

Equality Impact Assessment (Guidance development) (PDF 141 KB)

Register of interests (PDF 266 KB)

Final draft guidance

Final appraisal document (PDF 154 KB)

Committee papers (PDF 2.84 MB)

Final scope (PDF 203 KB)

Final stakeholder list (PDF 187 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 387 KB)

Equality impact assessment (Scoping) (PDF 122 KB)

Draft scope post referral (PDF 223 KB)

Draft matrix post referral (PDF 185 KB)